Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,693.51
(
-0.34%
)
US TECH 100
24,060.00
(
-0.30%
)
Dow Jones
46,789.21
(
-0.43%
)
Brent Oil
105.61
(
4.92%
)
Bitcoin
72,368.66
(
-2.13%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: DewDiligence post# 119699

Monday, 05/09/2011 4:51:01 PM

Monday, May 09, 2011 4:51:01 PM

Post# of 257253
>NVO

Maybe I haven't focused enough on FOB's for their insulin products. In this environment having marginally better new products probably isn't enough to protect them. I expect Victoza to do very well, but maybe that's not enough to compensate.

But if not NVO, then what's the buy-and-forget diabetes play?

Peter
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now